Pizzagalli, D. A., Smoski, M., Ang, Y.-S., Whitton, A. E., Sanacora, G., Mathew, S. J., … Krystal, A. D. (2021). Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology, 46(12), 2224. https://doi.org/10.1038/s41386-021-01145-9

Pizzagalli, Diego A., Moria Smoski, Yuen-Siang Ang, Alexis E. Whitton, Gerard Sanacora, Sanjay J. Mathew, John Nurnberger, et al. “Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).” Neuropsychopharmacology 46, no. 12 (November 2021): 2224. https://doi.org/10.1038/s41386-021-01145-9.

Pizzagalli DA, Smoski M, Ang Y-S, Whitton AE, Sanacora G, Mathew SJ, et al. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology. 2021 Nov;46(12):2224.

Pizzagalli, Diego A., et al. “Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS).” Neuropsychopharmacology, vol. 46, no. 12, Nov. 2021, p. 2224. Pubmed, doi:10.1038/s41386-021-01145-9.

Pizzagalli DA, Smoski M, Ang Y-S, Whitton AE, Sanacora G, Mathew SJ, Nurnberger J, Lisanby SH, Iosifescu DV, Murrough JW, Yang H, Weiner RD, Calabrese JR, Goodman W, Potter WZ, Krystal AD. Correction to: Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS). Neuropsychopharmacology. 2021 Nov;46(12):2224.